Royal Philips’ IGT Goes For The Structural Heart
Value Based Concepts Also Apply In Diagnosis And Treatment
Executive Summary
Royal Philips’ image-guided therapy business has rebounded, as expected, after the COVID-19 dip, and is now targeting expansion in a number of areas, as business leader Bert van Meurs explains.
You may also be interested in...
Spectranetics Gives Philips Adjacent Territory In Image-Guided Therapy
The plum in the middle of Philips' intense period of M&A this summer was the €1.9 billion purchase of Spectranetics, which, combined with Philips Volcano, should create a $1 billion+ devices business within the image-guided therapy group by 2020. IGT senior vice president and general manager Bert van Meurs explains the rationale behind the deal, and what's next for Philips.
Seven Trending Technologies On The Cusp Of Mainstream Uptake
At HIMSS22, NEO.Life’s Jane Metcalfe identified seven trending technologies that are set to move from the fringes of medicine to the center of attention.
Regulation, Digitization Mulled As Swiss Medtechs Look To An ‘EU+’ Vision For The Future
With Switzerland now operating as a third country to the EU, Swiss-based medtech manufacturers are keen to maximize their inherent advantages and build a basis for future growth.